Furthermore, plasma membrane-anchored IL30 may orchestrate the genetic and immunological reprogramming of neighboring cancer cells by boosting the expression of oncogenes, growth factors, chemokine receptors, inflammatory mediators and checkpoint regulators, while turning off tumor suppressor genes. The gene discussed is IL27; the disease is neoplasm.